Gastric cancer is still an important disease causing many deaths worldwide, although there
has been a marked reduction in prevalence during the last few decades. The decline in …

Gastric neuroendocrine neoplasms (gNENs) display peculiar site-specific features among
all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs …

This document represents the first position statement produced by the British Society of
Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and …

Gastric cancer accounts for about 6% of cancers worldwide, being the fifth most frequently
diagnosed malignancy and the third leading cause of cancer related death. Gastric …

Background & Aims There have been increasing numbers of case reports and observational
studies of adverse events in patients receiving long-term therapy with proton pump inhibitors …

This is one of a series of statements discussing the use of GI endoscopy in common clinical
situations. The Standards of Practice Committee of the American Society for Gastrointestinal …

Gastric cancer is the fourth most common malignancy and the second leading cause of
cancer-related death worldwide. 1 Although the incidence of gastric cancer in North America …

The clinical benefits of BRAF inhibition in patients with advanced-stage BRAF-mutant
melanoma are now well established. Although the emergence of cutaneous squamous-cell …

4% of patients who undergo gastric biopsy have gastric polyps. These lesions may be true
epithelial polyps, heterotopias, lymphoid tissue, or stromal lesions. Hyperplastic polyps …

The liberal use of upper endoscopy has led to an increased detection of gastric and
duodenal polyps, which are identified in as many as 6 and 4.6% of patient examinations …